Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP230373.RAVSbGZcRUE5U8G3GO4hETPduD9f8eNpISzbvjzMD88oM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP230373.RAVSbGZcRUE5U8G3GO4hETPduD9f8eNpISzbvjzMD88oM130_assertion type Assertion NP230373.RAVSbGZcRUE5U8G3GO4hETPduD9f8eNpISzbvjzMD88oM130_head.
- NP230373.RAVSbGZcRUE5U8G3GO4hETPduD9f8eNpISzbvjzMD88oM130_assertion description "[PEG-IFN-alfa 2b 1.5 microg/kg/wk was superior to IFN-alfa 2b in decreasing mean serum hepatitis C RNA ( P < .05 at week 12).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP230373.RAVSbGZcRUE5U8G3GO4hETPduD9f8eNpISzbvjzMD88oM130_provenance.
- NP230373.RAVSbGZcRUE5U8G3GO4hETPduD9f8eNpISzbvjzMD88oM130_assertion evidence source_evidence_literature NP230373.RAVSbGZcRUE5U8G3GO4hETPduD9f8eNpISzbvjzMD88oM130_provenance.
- NP230373.RAVSbGZcRUE5U8G3GO4hETPduD9f8eNpISzbvjzMD88oM130_assertion SIO_000772 15952104 NP230373.RAVSbGZcRUE5U8G3GO4hETPduD9f8eNpISzbvjzMD88oM130_provenance.
- NP230373.RAVSbGZcRUE5U8G3GO4hETPduD9f8eNpISzbvjzMD88oM130_assertion wasDerivedFrom befree-20140225 NP230373.RAVSbGZcRUE5U8G3GO4hETPduD9f8eNpISzbvjzMD88oM130_provenance.
- NP230373.RAVSbGZcRUE5U8G3GO4hETPduD9f8eNpISzbvjzMD88oM130_assertion wasGeneratedBy ECO_0000203 NP230373.RAVSbGZcRUE5U8G3GO4hETPduD9f8eNpISzbvjzMD88oM130_provenance.